Alphinity Investment Management Pty LTD Eli Lilly & CO Transaction History

Alphinity Investment Management Pty LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $10.4 Million - $12.2 Million	-37,302 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$234.69 - $291.66 $1.69 Million - $2.1 Million	-7,216 Reduced 16.21%	37,302 $10.7 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $2.64 Million - $3.28 Million	11,750 Added 35.86%	44,518 $12.3 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $4.94 Million - $6.08 Million	-22,298 Reduced 40.49%	32,768 $7.57 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $72.9 Million - $94.3 Million	-403,659 Reduced 88.0%	55,066 $12.6 Million

Q1 2021 Apr 23, 2021	BUY	$164.32 - $212.72 $21.6 Million - $27.9 Million	131,359 Added 40.13%	458,725 $85.7 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $8.75 Million - $11.6 Million	67,068 Added 25.77%	327,366 $55.3 Million
Q3 2020 Feb 10, 2021	BUY	$146.22 - $169.13 $38.1 Million - $44 Million	260,298 New	260,298 $38.5 Million

3,747

737M

7.09M

7.22M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $815B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Alphinity Investment Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Alphinity Investment Management Pty LTD with notifications on news.